Cite
HARVARD Citation
Tsao, N. et al. (2014). A Budget Impact Analysis of the Introduction of Erythropoiesis Stimulating Agent Subsequent Entry Biologics for the Treatment of Anemia of Chronic Kidney Disease in Canada. Canadian journal of kidney health and disease =. 1 (1), p. . [Online].